– Leading Experts to Discuss Clinical Programs in Primary Liver Cancer and Ovarian Cancer LAWRENCEVILLE, N.J., Oct. 12, 2017 (GLOBE NEWSWIRE) — Celsion Corporation (NASDAQ:CLSN), an oncology development company, today announced that it will host a Research and Development (R&…
Source: BioSpace